Search results for "Stroke"

showing 10 items of 1226 documents

Phenotypic APC resistance as a marker of hypercoagulability in primitive cerebral lymphoma

2005

Thrombosis is the most frequent complication and the second cause of death in patients with malignant disease. Primary central nervous system non-Hodgkin's lymphoma represents a rare pathology. Resistance to APC is usually linked to a factor V (FV) gene mutation changing an Arg 506 to a Gln in the APC cleavage site.In our study, we aimed at investigating the presence of activated protein C resistance (APC-r) and other markers of hypercoagulability in 25 selected patients with a diagnosis of primitive cerebral lymphoma who had suffered from an ischemic episode of TIA and/or stroke.25 selected patients with a diagnosis of primitive cerebral lymphoma and 50 healthy subjects acted as control gr…

Brain NeoplasmsLymphoma Non-HodgkinFactor VPeptide FragmentsBrain NeoplasmStrokePhenotypePeptide FragmentIschemic Attack TransientCase-Control StudiesMutationPlasminogen Activator Inhibitor 1HumansProthrombinCase-Control StudieBlood CoagulationBiomarkersHumanActivated Protein C Resistance
researchProduct

2015

The recombinant form of tissue plasminogen activator (rt-PA) is the only curative treatment for ischemic stroke. Recently, t-PA has been linked to the metabolism of brain-derived neurotrophic factor (BDNF), a major neurotrophin involved in post-stroke neuroplasticity. Thus, the objective of our study was to investigate the impact of rt-PA treatment on post-stroke circulating BDNF levels in humans and in animals. Serum BDNF levels and t-PA/plasmin activity were measured at hospital admission and at up to 90 days in stroke patients receiving (n = 24) or not (n = 14) rt-PA perfusion. We investigated the relationships between serum BDNF with concurrent t-PA/plasmin activity, neurological outcom…

Brain-derived neurotrophic factor0303 health sciencesmedicine.medical_specialtyPathologyMultidisciplinaryPlasminbusiness.industrymedicine.diseaseTissue plasminogen activator3. Good healthBrain ischemia03 medical and health sciences0302 clinical medicineEndocrinologyBlood pressurenervous systemInternal medicinemedicineEndothelial dysfunctionbusinessStroke030217 neurology & neurosurgeryFibrinolytic agent030304 developmental biologymedicine.drugPLOS ONE
researchProduct

Development and validation of the neighborhood environment walkability scale for youth across six continents

2019

Abstract Background The IPEN International Physical Activity and Environment Network Adolescent project was conducted using common study protocols to document the strength, shape, and generalizability of associations of perceived neighborhood environment attributes with adolescents’ physical activity and overweight/obesity using data from 15 countries. Countries did not use identical versions of the Neighborhood Environment Walkability Scale for Youth (NEWS-Y) to measure perceived neighborhood environment attributes. Therefore, this study derived a measurement model for NEWS-Y items common to all IPEN Adolescent countries and developed a scoring protocol for the IPEN Adolescent version of t…

Built environmentHealth BehaviorMedicine (miscellaneous)WalkingCardiovascularAdolescentsMedical and Health SciencesACCESSIBILITYDevelopmental psychology0302 clinical medicineResidence CharacteristicsSurveys and QuestionnairesMedicine and Health SciencesSOCIOECONOMIC-STATUS030212 general & internal medicinelcsh:RC620-627Built environmentPediatricNutrition and Dieteticslcsh:Public aspects of medicineIPEN ADULTGlobal16. Peace & justiceConfirmatory factor analysisStrokelcsh:Nutritional diseases. Deficiency diseasesWalkabilityScale (social sciences)HEALTH OUTCOMESRELIABILITYPublic Health0305 other medical sciencePsychologyBEHAVIORPediatric Research InitiativeAdolescentPARTICIPATIONeducationPhysical Therapy Sports Therapy and RehabilitationPooled analysesConfirmatory factor analysisEducation03 medical and health sciencesClinical ResearchBehavioral and Social ScienceMEASURED PHYSICAL-ACTIVITYHumansGeneralizability theoryObesityCategorical variableSocioeconomic statusExercise030505 public healthQuestionnairePreventionMethodologyConstruct validityReproducibility of Resultslcsh:RA1-1270social sciencesAdolescent BehaviorInternational Journal of Behavioral Nutrition and Physical Activity
researchProduct

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strat…

2021

Abstract Recent advances in human genetics, together with a large body of epidemiologic, preclinical, and clinical trial results, provide strong support for a causal association between triglycerides (TG), TG-rich lipoproteins (TRL), and TRL remnants, and increased risk of myocardial infarction, ischaemic stroke, and aortic valve stenosis. These data also indicate that TRL and their remnants may contribute significantly to residual cardiovascular risk in patients on optimized low-density lipoprotein (LDL)-lowering therapy. This statement critically appraises current understanding of the structure, function, and metabolism of TRL, and their pathophysiological role in atherosclerotic cardiova…

CHOLESTERYL ESTER TRANSFERTO-MODERATE HYPERTRIGLYCERIDEMIALipoprotein remnants030204 cardiovascular system & hematologyBioinformaticsResidual riskBrain Ischemiachemistry.chemical_compoundVoeding Metabolisme en Genomica0302 clinical medicineIschaemic strokeAcademicSubjects/MED00200Myocardial infarctionLOW-GRADE INFLAMMATIONALL-CAUSE MORTALITY[SDV.MHEP.EM] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism0303 health sciencesAtherosclerotic cardiovascular diseasedigestive oral and skin physiology[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismCardiovascular diseaseMetabolism and Genomics3. Good healthStrokeLOW-DENSITY LIPOPROTEINSCardiovascular DiseasesMetabolisme en GenomicaCORONARY-ARTERY-DISEASENutrition Metabolism and GenomicsCardiology and Cardiovascular MedicineB-CONTAINING LIPOPROTEINSLipoproteinsTriglyceride-rich lipoproteinsHEART-DISEASE03 medical and health sciencesSpecial ArticleVoedingmedicineHumansHOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIATriglycerides030304 developmental biologyNutritionVLAGTriglyceridebusiness.industryAPO-Bmedicine.diseaseAtherosclerosisResidual riskIncreased riskchemistry3121 General medicine internal medicine and other clinical medicineEuropean atherosclerosis societybusinessLipoprotein
researchProduct

Global Impact of the COVID-19 Pandemic on Stroke Volumes and Cerebrovascular Events: One-Year Follow-up

2023

Background and objectives: Declines in stroke admission, intravenous thrombolysis, and mechanical thrombectomy volumes were reported during the first wave of the COVID-19 pandemic. There is a paucity of data on the longer-term effect of the pandemic on stroke volumes over the course of a year and through the second wave of the pandemic. We sought to measure the impact of the COVID-19 pandemic on the volumes of stroke admissions, intracranial hemorrhage (ICH), intravenous thrombolysis (IVT), and mechanical thrombectomy over a one-year period at the onset of the pandemic (March 1, 2020, to February 28, 2021) compared with the immediately preceding year (March 1, 2019, to February 29, 2020). M…

COVID-19; acute stroke; intracranial hemorrhage; intravenous thrombolysis; ischemic stroke; mechanical thrombectomyNeurology
researchProduct

Energy compensation and adiposity in humans

2021

Publisher Copyright: © 2021 The Authors Understanding the impacts of activity on energy balance is crucial. Increasing levels of activity may bring diminishing returns in energy expenditure because of compensatory responses in non-activity energy expenditures.1–3 This suggestion has profound implications for both the evolution of metabolism and human health. It implies that a long-term increase in activity does not directly translate into an increase in total energy expenditure (TEE) because other components of TEE may decrease in response—energy compensation. We used the largest dataset compiled on adult TEE and basal energy expenditure (BEE) (n = 1,754) of people living normal lives to fi…

Calorie030309 nutrition & dieteticsEnergy balanceRA773SDG 3 – Goede gezondheid en welzijnCardiovascularMedical and Health SciencesOral and gastrointestinalCompensation (engineering)RC12000302 clinical medicineWeight lossenergy compensationAdiposityCancer0303 health sciencesexerciseCONSTRAINTBiological SciencesStrokeIAEA DLW database groupEXERCISE PHYSICAL-ACTIVITYmedicine.symptomGeneral Agricultural and Biological SciencesINTERVENTIONSEnergy (esotericism)WEIGHT-LOSS030209 endocrinology & metabolismMASSBiologyArticleGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciencesAffordable and Clean EnergySDG 3 - Good Health and Well-beingTotal energy expenditureClinical Researchdaily energy expendituremedicineVDP::Matematikk og Naturvitenskap: 400::Basale biofag: 470HumansBASALObesityMetabolic and endocrineenergy management modelsNutritionHomo sapiensBIRDSactivityPsychology and Cognitive Sciencesmedicine.diseaseObesitytrade-offsMETABOLIC-RATESBasal metabolic ratebasal metabolic rate1182 Biochemistry cell and molecular biologyDemographic economics3111 Biomedicineweight lossEnergy MetabolismEnergy IntakeEXPENDITUREDevelopmental Biology
researchProduct

Role of two sequence motifs of mesencephalic astrocyte-derived neurotrophic factor in its survival-promoting activity

2015

AbstractMesencephalic astrocyte-derived neurotrophic factor (MANF) is a prosurvival protein that protects the cells when applied intracellularly in vitro or extracellularly in vivo. Its protective mechanisms are poorly known. Here we studied the role of two short sequence motifs within the carboxy-(C) terminal domain of MANF in its neuroprotective activity: the CKGC sequence (a CXXC motif) that could be involved in redox reactions, and the C-terminal RTDL sequence, an endoplasmic reticulum (ER) retention signal. We mutated these motifs and analyzed the antiapoptotic effect and intracellular localization of these mutants of MANF when overexpressed in cultured sympathetic or sensory neurons. …

Cancer ResearchCell SurvivalImmunologyMutantAmino Acid MotifsIntracellular SpaceGolgi ApparatusSuperior Cervical GanglionBiologyRats Sprague-DawleyCellular and Molecular Neurosciencesymbols.namesakeMiceStructure-Activity RelationshipMutant proteinNeurotrophic factorsGanglia SpinalExtracellularAnimalsCysteineNerve Growth FactorsEtoposideSequence DeletionEndoplasmic reticulumprosurvival proteinsta1182Cell BiologyGolgi apparatusMolecular biologyRecombinant ProteinsStrokeDisease Models AnimalProtein Transportmesencephalic astrocyte-derived neurotrophic factorNeuroprotective AgentsMutationsymbolsOriginal ArticleSequence motifIntracellularCell Death and Disease
researchProduct

Epigenomics in acute cerebrovascular diseases.

2020

Cancer ResearchMEDLINEBiologyDNA MethylationBioinformaticsBrain IschemiaEpigenesis GeneticCerebrovascular DisordersMicroRNAsDNA methylationGeneticsHumansEpigenesisEpigenomicsIschemic StrokeEpigenomics
researchProduct

Key lncRNAs involved in ischemic strokes

2022

NA

Cancer Researchmedicine.medical_specialtyIschemic strokesBiologymedicine.diseaseBrain Ischemiaischemic stroke lncRNAs miRNAs RNA transcripts stroke Humans Brain Ischemia Ischemic Stroke RNA Long NoncodingInternal medicineIschemic strokeGeneticsKey (cryptography)medicineCardiologyHumansRNA Long NoncodingStrokeIschemic StrokeEpigenomics
researchProduct

Neuroinflammatory mechanisms in ischemic stroke: Focus on cardioembolic stroke, background, and therapeutic approaches

2020

One of the most important causes of neurological morbidity and mortality in the world is ischemic stroke. It can be a result of multiple events such as embolism with a cardiac origin, occlusion of small vessels in the brain, and atherosclerosis affecting the cerebral circulation. Increasing evidence shows the intricate function played by the immune system in the pathophysiological variations that take place after cerebral ischemic injury. Following the ischemic cerebral harm, we can observe consequent neuroinflammation that causes additional damage provoking the death of the cells; on the other hand, it also plays a beneficial role in stimulating remedial action. Immune mediators are the or…

Cardiac embolismNeuroimmunomodulationIschemiaInflammationReview030204 cardiovascular system & hematologyBioinformaticsCatalysisProinflammatory cytokineBrain IschemiaInorganic Chemistrylcsh:Chemistry03 medical and health sciencesCerebral circulation0302 clinical medicineImmune systemNeuroinflammationmedicineAnimalsHumansPhysical and Theoretical ChemistryMolecular Biologylcsh:QH301-705.5SpectroscopyNeuroinflammationInflammationEmbolic StrokeIschemic strokebusiness.industryOrganic ChemistryBrainGeneral Medicinemedicine.diseasePathophysiologyComputer Science ApplicationsStrokeEmbolismlcsh:Biology (General)lcsh:QD1-999Cytokinesmedicine.symptombusiness030217 neurology & neurosurgery
researchProduct